Estonian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
Leht 1 alates 18 tulemused
Tumor Hypoxia and Proliferation in Patients With High-Grade Glioma
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
This is a pilot study to assess a novel methodology recently developed to simultaneously image tumor hypoxia and proliferation by means of simultaneous FMISO and FLT PET acquisition. FMISO (18F-Fluoromisonidazole) PET is a non-invasive method for detecting tumor hypoxia in solid tumors. FLT
A Study of Low Dose Bevacizumab With Conventional Radiotherapy Alone in Diffuse Intrinsic Pontine Glioma
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
In tumours like Diffuse pontine glioma (DIPG), the diagnosis itself spells a death sentence for the child affected. The current standard treatment is conventionally fractionated daily radiation treatment for 6 weeks which benefits 80-90% patients with temporary improvement in neurological function
Hyperbaric Radiation Sensitization of Head and Neck Cancers
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
The goal of this research is to address the question:
"Does the addition of hyperbaric oxygen to radiation and chemotherapy improve outcomes in locally advanced oropharyngeal or laryngeal squamous cell carcinoma?"
There is reason to believe that hyperbaric oxygen administered immediately prior to
Apatinib Combined With Radiotherapy in Patient With BM From Drive Gene Negative NSCLC
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Brain metastases (BM) develop in 22-54% of NSCLC patients during the disease course. NSCLC patients with BM with a median overall survival (OS) of 2-3 months when treated with systemic corticosteroid alone, and a median OS of 3-6 months when treated with whole brain radiation therapy (WBRT).
TMZ Plus Apatinib in Newly Diagnosed High-grade Glioma：RCT
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Glioma is the most common primary malignant Brain Tumor.High grade glioma (HGG) has the characteristics of high morbidity, high relapse and high incidence of causing disability.Despite the progress in the combined treatment of surgery, radiotherapy and chemotherapy, the 2-year survival rate and
Multimodal Imaging of Hypoxia in Gliomas
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
IA Carboplatin + Radiotherapy in Relapsing GBM
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
A phase II study in relapsing glioblastomas (GBM) using concurrent intraarterial carboplatin chemoradiation therapy.
BACKGROUND - Contemporary treatment of GBM brain tumors involves a first-line treatment in which the patient receives a surgical procedure followed by a combination of radiation and
FET-PET and Multiparametric MRI for High-grade Glioma Patients Undergoing Radiotherapy
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
A Study of Apatinib for Advanced Hepatocellular Carcinoma Patients After First-line Treatment Failure
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Low-dose Intra-arterial Bevacizumab for Edema and Radiation Necrosis Therapeutic Intervention (LIBERTI)
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
BACKGROUND Radiation Necrosis: Stereotactic radiosurgery has become integral in treatment of brain tumors and arteriovenous malformations (AVM). In up to 10% of cases, this can lead to radiation necrosis (RN) with significant surrounding vasogenic edema and mass effect. Medical treatment for RN
Tumor Hypoxia With HX4 PET in Several Diseases
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Rationale: Non-invasive imaging of hypoxia with the aid of PET-scans could help to select the patients having a hypoxic tumor, who could be treated with specific anti-hypoxic treatments. The added value of additional anti-hypoxic treatments depends on the presence of hypoxia and adequate patient
Retrospective Evaluation of Melanocortin Receptor 4 Polymorphisms in Patients With GBM Treated With Radiochemotherapy
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Glioma is the most frequent malignant primary brain tumor and remains a lethal disease with a dismal prognosis. Glioblastoma (GBM) accounts approximately 50% of all glioma and among these tumors, are the most malignant. GBM are characterized by a higher cellular density and by the ample existence of
The Etiology and Progression of Brain Tumors
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Aims of the study:
1. To collect adequate brain cancer tissue material for high throughput morphological, protein, RNA and DNA analyses.
2. To combine tissue-related results of these analyses with clinical data to examine the potential of the new biomarkers to assess diagnosis, prognosis and
Safety Evaluation of a Combination of Brain Radiation Therapy and Bevacizumab (Avastin®) for Treatment of Brain Metastasis
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Brain metastasis remain a common complication of many solid tumors, occurring from 10 to 20% of patients with cancer, and the incidence may arise up to 20-40% in autopsy series. Despite the treatment, the patient outcome is poor and brain metastasis become a major cause of death from cancer.
Some
HYPONCO - Hypoxia in Brain Tumors
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Kõige täiuslikum ravimtaimede andmebaas, mida toetab teadus
- Töötab 55 keeles
- Taimsed ravimid, mida toetab teadus
- Maitsetaimede äratundmine pildi järgi
- Interaktiivne GPS-kaart - märgistage ürdid asukohas (varsti)
- Lugege oma otsinguga seotud teaduspublikatsioone
- Otsige ravimtaimi nende mõju järgi
- Korraldage oma huvisid ja hoidke end kursis uudisteuuringute, kliiniliste uuringute ja patentidega
Sisestage sümptom või haigus ja lugege ravimtaimede kohta, mis võivad aidata, tippige ürdi ja vaadake haigusi ja sümptomeid, mille vastu seda kasutatakse.
* Kogu teave põhineb avaldatud teaduslikel uuringutel
